Table 2. Total Numbers of Plasma and PBMC Samples from individuals with Spontaneous Resolution of Hepatitis C And Results on HCV Detection.
Plasma | PBMC | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
HCV RNA+ Positivity | HCV RNA+ Positivity | HCV RNA- Positivity | ||||||||||
Sample Collection | Total Sample Tested | 250 μl | 5 ml | Total Positivity (%) | Total Samples Tested | PHA-Treated | C5-Treated | Total Positivity (%) | Samples Tested* | PHA- Treated | C5Treated | Total Positivity (%) |
First | 24 | 11 | 3 | 14/24 | 23 | 11 | NA | 11/23 | 11 | 11 | NA | 7/11 |
(58.3%) | (47.8%) | (63.6%) | ||||||||||
Second | 9 | 1 | 3 | 4/9 | 9 | 2 | 3 | 5/9 | 5 | 2 | 3 | 45 |
(44.4%) | (55.6%) | (80%) |
PBMC, peripheral blood mononuclear cells; HCV RNA+, HCV RNA positive strand; HCV RNA-, HCV RNA negative strand; PHA, phytohemagglutinin; C5, immune cell stimulating cocktail (see Materials and Methods); NA, not applicable.
*Tested only when the sample found HCV RNA positive strand reactive.